|
CCDC59 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.67754699020861E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
6.785200E-01 |
| Stage1-vs-Stage3 |
2.557800E-02 |
| Stage1-vs-Stage4 |
1.048340E-02 |
| Stage2-vs-Stage3 |
2.346200E-01 |
| Stage2-vs-Stage4 |
1.833610E-01 |
| Stage3-vs-Stage4 |
8.681800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.64210020318023E-10 |
| Normal-vs-Asian |
1.99418259683171E-12 |
| Caucasian-vs-AfricanAmerican |
8.201800E-01 |
| Caucasian-vs-Asian |
1.580210E-01 |
| AfricanAmerican-vs-Asian |
2.365200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62503344114384E-12 |
| Male-vs-Female |
2.711200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11022302462516E-15 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.09560027716782E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.617800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.620500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.188400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.178600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.226200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.171800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.591900E-02 |
| Classical-VS-Follicular |
4.563800E-01 |
| Classical-VS-Other |
5.205000E-01 |
| Classical-VS-Normal |
8.10462807976364E-15 |
| Tall-VS-Follicular |
2.959900E-02 |
| Tall-VS-Other |
1.157240E-01 |
| Tall-VS-Normal |
2.77555756156289E-15 |
| Follicular-VS-Other |
8.512200E-01 |
| Follicular-VS-Normal |
2.72126765565872E-12 |
| Other-VS-Normal |
1.117110E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62614366416847E-12 |
| N0-vs-N1 |
9.302400E-01 |
|
|
